期刊： GASTRIC CANCER, 2022; 25 (6)
Background Accurate pre-treatment prediction of neoadjuvant chemotherapy (NACT) resistance in patients with locally advanced gastric cancer (LAGC) is ......
期刊： GASTRIC CANCER, 2022; 25 (6)
Background A disintegrin and metalloproteinase with thrombospondin motifs 10 (ADAMTS10) plays a role in extracellular matrix and correlates with Weill......
期刊： GASTRIC CANCER, 2022; 25 (1)
Gastric cancer (GC) is a common malignant solid tumor that is characterized by high hypoxia. The transcription of genes associated with hypoxia affect......
期刊： GASTRIC CANCER, 2022; 25 (2)
Background Peritoneum, liver and lymph node are the most common metastatic sites of gastric cancer (GC). Biomarkers for GC's organo-tropic metastasis ......
期刊： GASTRIC CANCER, 2022; 25 (4)
Background The overlap guiding tube (OGT) method, which was designed by our team to assist in overlap esophagojejunostomy, could potentially provide n......
期刊： GASTRIC CANCER, 2022; 25 (2)
Background Cancer-associated fibroblasts (CAFs) are the most principal cells of depositing and remodeling extracellular matrix (ECM) within solid tumo......
期刊： GASTRIC CANCER, 2022; 25 (4)
Background Distinguishing gastric epithelial regeneration change from dysplasia and histopathological diagnosis of dysplasia is subject to interobserv......
期刊： GASTRIC CANCER, 2022; 25 (5)
Objective Endoscopic resection (ER) is an effective treatment method for gastric submucosal tumors (G-SMTs), but endoscopic resection failure requires......
期刊： GASTRIC CANCER, 2022; 25 (3)
Background Fibroblasts are the predominant cell type in the stroma of tumor, and cancer-associated fibroblasts (CAFs) promote cancer chemoresistance b......
期刊： GASTRIC CANCER, 2022; 25 (5)
Background A complex microbiota in the gastric mucosa (GM) has been unveiled recently and its dysbiosis is identified to be associated with gastric ca......
期刊： GASTRIC CANCER, 2022; 25 (4)
Background Helicobacter pylori (H. pylori) has been recognized as the class I carcinogen of gastric cancer and several studies have demonstrated that ......
期刊： GASTRIC CANCER, 2022; 25 (3)
Background Increasing evidence indicates that leucine-rich-alpha-2-glycoprotein 1 (LRG1) is associated with multiple malignancies, but whether it part......
